Personalized Medicine: Gene-Driven and Targeted Diagnostics
More than 1,600 genetic tests are currently available
Read More
Search Results for: lung cancer
New MicroRNA-Based Diagnostic Test Now Commercially Available
Rosetta Genomics, Ltd has announced the commercial availability of its second diagnostic test, miRview mets. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.
Read MorePatients Face Higher Health Care Costs in US than Other Western Countries
A 2008 survey of chronically ill adults in Western countries found major differences in health care access, safety, and efficiency, with US patients at high risk of forgoing care because of costs.
Read MoreChildren with Cystic Fibrosis Not Well Covered by Guidelines for Vitamin D Needs
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Childrens Center.
Read MoreDxS Announces License Agreement with Wellcome Trust
DxS has signed a non-exclusive global licensing agreement with the Wellcome Trust. DxS will provide a research test for use in clinical trials to detect the presence of the V600E B-RAF mutation, which is found in melanomas, lung and thyroid cancers.
Read More